Sex and acquired cofactors determine phenotypes of ferroportin disease.

Abstract : BACKGROUND & AIMS: Ferroportin disease is characterized by iron overload. It has an autosomal-dominant pattern of inheritance and has been associated with mutations in the SLC40A1 gene, which encodes the cellular iron exporter ferroportin. Since the first description in 2001, about 30 mutations have been reported; the heterogeneity of ferroportin disease phenotypes has led to the hypothesis that the nature of the mutation affects the function of the protein in different ways. We studied genotypes and phenotypes of a large cohort of patients with ferroportin disease. METHODS: We studied clinical, biochemical, imaging, histologic, and genetic data from 70 affected subjects from 33 families with 19 mutations. RESULTS: We found that ferroportin disease, at the time of diagnosis, has limited consequences in the absence of cofactors. Data indicated that transferrin saturation, which correlated with fibrosis and levels of alanine aminotransferase, might be a marker of disease severity. Although the study was performed in a large number of families, we observed incomplete penetrance and no correlation between genotypes and phenotypes. CONCLUSIONS: Members of families with ferroportin disease should be screened for biochemical parameters of iron metabolism as well as genotype to detect silent mutations that might cause disease with acquired or genetic cofactors. Patients should be followed up long term to identify potential complications of the disease.
Type de document :
Article dans une revue
Gastroenterology, WB Saunders, 2011, 140 (4), pp.1199-1207.e1-2. 〈10.1053/j.gastro.2010.12.049〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00554693
Contributeur : Hervé De Villemeur <>
Soumis le : mardi 11 janvier 2011 - 10:09:42
Dernière modification le : lundi 26 mars 2018 - 15:23:25

Identifiants

Citation

Caroline Le Lan, Annick Mosser, Martine Ropert, Lénaïck Detivaud, Véronique Loustaud-Ratti, et al.. Sex and acquired cofactors determine phenotypes of ferroportin disease.. Gastroenterology, WB Saunders, 2011, 140 (4), pp.1199-1207.e1-2. 〈10.1053/j.gastro.2010.12.049〉. 〈inserm-00554693〉

Partager

Métriques

Consultations de la notice

192